Investigative Site US066 — Maple Grove, Minnesota

Investigative Site US066 is a clinical research site located in Maple Grove, Minnesota, United States 55369.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site US066 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors.

Sponsors: Incyte Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Maple Grove

Browse all research sites in Minnesota · View every site in Maple Grove

• Maple Grove Hospital
• University of Minnesota Medical Center
• St. John's hospital
• University of Minnesota Health Maple Grove Clinics
• University of Minnesota Health Maple Grove Clinic
• University of Minnesota
• Fairview Clinics and Surgery Center Maple Grove
• Fairview Maple Grove Medical Center
• Minnesota Oncology - Maple Grove
• Minnesota Oncology Hematology, P.A.
• Minnesota Oncology Hematology
• Minnesota Oncology Hematology PA

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site US066?

Investigative Site US066 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site US066 conducted?

Investigative Site US066 has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumors.

Is Investigative Site US066 accredited by Crixeo Clinical Trials?

Investigative Site US066 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site US066?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.